comparemela.com

Page 29 - சைகடெலிக் ஆய்வுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Joint feasibility assessment of Bionomics BNC210 and EmpathBio s MDMA derivative EMP-01 treatment regimen for PTSD

News Category Global Banking & Finance Reviews Joint feasibility assessment of Bionomics BNC210 and EmpathBio s MDMA derivative EMP-01 treatment regimen for PTSD ADELAIDE, Australia, Feb. 17, 2021 /PRNewswire/  Bionomics Limited (ASX: BNO, OTCQB: BNOEF, Germany: AU000000BNO5) ( Bionomics) today announced that it has entered into a Memorandum of Understanding with EmpathBio Inc ( EmpathBio), a wholly owned subsidiary of Germany-based CNS clinical development company, atai Life Sciences ( atai). Under the Memorandum of Understanding, Bionomics and EmpathBio propose to collectively explore a combination drug treatment regimen with Bionomics BNC210 and EmpathBio s 3,4-Methylenedioxymethamphetamine (MDMA) derivative EMP-01. The parties will explore whether the different mechanisms of action of EMP-01 and BNC210 may offer the potential for developing an improved treatment regimen for the treatment of Post-Traumatic Stress Disorder (PTSD).

Canada s Largest Psychedelic Industry Conference to Coincide with Mental Health Awareness Week, Offering Hope to the Current Mental Health Crisis

Canada s Largest Psychedelic Industry Conference to Coincide with Mental Health Awareness Week, Offering Hope to the Current Mental Health Crisis News provided by Share this article Share this article Among the featured agenda of international speakers will be Michael Pollan, Journalist and Author of the #1 New York Times Best-Seller, How To Change Your Mind CALGARY, AB, March 3, 2021 /CNW/ - CATALYST Presents Foundation ( CATALYST ), an Alberta-based not-for-profit event company focused on advancing the psychedelic medicine movement in Canada, announced the second annual  CATALYST Summit 2021, Canada s largest conference in the psychedelic medicine arena. Tickets for the influential event went on sale this week and are expected to be in strong demand with psychedelics becoming a hot topic in mental health.

Non-Traditional Therapies Could Fill Vital Mental Health Needs

Non-Traditional Therapies Could Fill Vital Mental Health Needs - FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, March 2, 2021 /PRNewswire/ Non-traditional therapies are coming a long way from their stigmatized roots. Rising rates of serious mental health issues and unreliability of traditional mental health treatments have spurred research into treatment forms utilizing once stigmatized and criminalized drugs. The results have been promising enough that the pharmaceutical industry around therapeutic MDMA, ketamine, psilocybin, and other psychoactive substances is taking shape and gaining momentum. Non-traditional therapies are gaining government regulatory approval and, in some cases, even breakthrough therapy designations, and the companies moving this revolution forward like

HMP Global Launches Groundbreaking Sana Symposium, with Psychedelics Education to Transform Mental Healthcare

HMP Global Launches Groundbreaking Sana Symposium, with Psychedelics Education to Transform Mental Healthcare
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.